• Home
  • NEW DAY MEDICINE
  • 8 (70) 2024
  • 43 -8 (70) 2024 - Kabilova D.K., Kuchkarov Sh.B. - RISK STRATIFICATION OF STROKE AND SYSTEMIC THROMBOEMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION

43 -8 (70) 2024 - Kabilova D.K., Kuchkarov Sh.B. - RISK STRATIFICATION OF STROKE AND SYSTEMIC THROMBOEMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION

RISK STRATIFICATION OF STROKE AND SYSTEMIC THROMBOEMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION

Kabilova D.K. - CAMU Central Asian Medical University International Medical University Fergana

Kuchkarov Sh.B. - CAMU Central Asian Medical University International Medical University Fergana

Resume

Atrial fibrillation is one of the most common cardiac arrhythmias. Atrial fibrillation is often complicated by thromboembolism, which leads to a deterioration in the quality of life of patients and also affects the prognosis of the disease. Considering the sufficient number of concomitant diseases that increase the risk of developing this complication, it is advisable to consider them as risk factors.

Key words: atrial fibrillation, thromboembolism, ischemic stroke.

First page

232

Last page

237

For citation:Kabilova D.K., Kuchkarov Sh.B. - RISK STRATIFICATION OF STROKE AND SYSTEMIC THROMBOEMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION//New Day in Medicine 8(70)2024 232-237 https://newdayworldmedicine.com/en/new_day_medicine/8-70-2024

List of References

  1. Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC, //European Heart Journal, 1 February 2021;42(5):373-498, https://doi.org/10.1093/eurheartj/ehaa612
  2. Banerjee A, Taillandier S, Olesen JB, et al. Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project. //Eur J Heart Fail 2012;14:295-301.Myerburg R.J., Kessler K.M., Castellanos A. Sudden cardiac death. Structure, function, and timedependence of risk.Circulation 1992; 85: 12-20.
  3. Jung H, Sung JH, Yang PS, et al. Stroke risk stratification for atrial fibrillation patients with hypertrophic cardiomyopathy. //J Am Coll Cardiol 2018;72:2409-2411.
  4. McMurray JJV, Ezekowitz JA, Lewis BS et al; ARISTOTLE Committees and Investigators.et al. Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation insights from the ARISTOTLE trial. //Circ Heart Fail 2013;6(3):451-60. DOI: 10.1161/CIRCHEARTFAILURE.112.000143.
  5. Pisters R., Lane DA., Marin F., Camm AJ., Lip GY. Stroke and thromboembolism in atrial fibrillation. //Circ J 2012;76:2289-2304.
  6. Kim D , Yang PS , Kim TH , et al. Ideal blood pressure in patients with atrial fibrillation. //J Am Coll Cardiol 2018;72:1233-1245.
  7. María Asunción Esteve-Pastor, José Miguel Rivera-Caravaca, Gregory YH Lip. Hypertension and Atrial Fibrillation: Balancing Stroke and Bleeding Risks, //American Journal of Hypertension, November 2017;30(11):1063-1065, https://doi.org/10.1093/ajh/hpx135.
  8. Overvad T.F., Skjoth F., Lip G.Y. et al. Duration of diabetes mellitus and risk of thromboembolism and bleeding in atrial fibrillation: nationwide cohort study. //Stroke 2015;46:2168-74.
  9. Patlolla SH, Lee HC, Noseworthy PA, Wysokinski WE, et al. Impact of Diabetes Mellitus on Stroke and Survival in Patients With Atrial Fibrillation. //Am J Cardiol. 2020 Sep 15;131:33-39. doi: 10.1016/j.amjcard.2020.06.049. Epub 2020 Jun 30. PMID: 32723556; PMCID: PMC7484039Ahmad Beik, Siyavash Joukar, Hamid Najafipour. A review on plants and herbal components with antiarrhythmic activities and their interaction with current cardiac drugs. Journal of Traditional and Complementary Medicine/ Volume 10, Issue 3, May 2020, Pages 275-287. https://doi.org/10.1016/j.jtcme.2020.03.002.
  10. Chao TF, Liu CJ, Liao JN, et al. Use of oral anticoagulants for stroke prevention in patients with atrial fibrillation who have a history of intracranial hemorrhage. //Circulation 2016;133:1540-1547.
  11. Bronnum Nielsen P, Larsen TB, Gorst-Rasmussen A, et al. Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study. //Chest 2015;147:1651-1658.
  12. Nielsen P.B., Larsen T.B., Skjoth F. et al. Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: a nationwide cohort study. //Circulation 2015;132:517-525.
  13. Lin L.Y., Lee C.H., Yu C.C. et al. Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation – a nation-wide database analysis. //Atherosclerosis 2011;217:292-295.
  14. Anandasundaram B., Lane D.A., Apostolakis S., Lip G.Y. The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review. //J Thromb Haemost 2013;11:975-987.
  15. Friberg L., Rosenqvist M., Lip G.Y. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. //Eur Heart J 2012;33:1500-1510.
  16. Steensig K, Olesen KKW, Thim T, et al. Should the presence or extent of coronary artery disease be quantified in the CHA2DS2-VASc score in atrial fibrillation? A report from the Western Denmark Heart Registry. //Thromb Haemost 2018;118:2162-2170.
  17. Zabalgoitia M., Halperin J.L., Pearce L.A. et al. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. //J Am Coll Cardiol 1998;31:1622-1626.
  18. Morseth B, Geelhoed B, Linneberg A On behalf of the MORGAM consortium, et alAge-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM ConsortiumOpen Heart 2021;8:e001624. doi: 10.1136/openhrt-2021-001624.
  19. Kim T.H., Yang P.S., Yu H.T. et al. Age threshold for ischemic stroke risk in atrial fibrillation. //Stroke 2018;49:1872-1879.
  20. Chao T.F., Wang K.L., Liu C.J. et al. Age threshold for increased stroke risk among patients with atrial fibrillation: a nationwide cohort study from Taiwan. //J Am Coll Cardiol 2015;66:1339-1347.

    file

    download